[Criteria of the patient's decision concerning vaccination against influenza AH1N1, in Belgium and France].
Identifieur interne : 000050 ( Main/Corpus ); précédent : 000049; suivant : 000051[Criteria of the patient's decision concerning vaccination against influenza AH1N1, in Belgium and France].
Auteurs : Frédéric Ketterer ; Yves Goffin ; Pierre Boyer ; Anne Freyens ; Adeline Sourbes ; Jean-Luc Belche ; Didier GietSource :
- Presse medicale (Paris, France : 1983) [ 2213-0276 ] ; 2013.
English descriptors
- KwdEn :
- MESH :
- chemical : Influenza Vaccines.
- geographic : Belgium, France.
- immunology : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human.
- Aged, Decision Making, Female, Humans, Male, Patient Acceptance of Health Care.
Abstract
INTRODUCTION
We have analyzed the reasons evoked by the patients to decide or not to be vaccinated against AH1N1 influenza, in France and Belgium.
METHODS
Semi-structured interviews were performed, recorded and transcribed for analysis. Fifty-eight interviews were performed with patient living in the region of Midi-Pyrénées, France (21 interviews) and in the province of Liège, Belgium (37 interviews). The patients were recruited by general practitioners. Within the sample, some patients were vaccinated against AH1N1 influenza and others were not.
RESULTS
Five criteria influenced the decision to be vaccinated or not: how people understand the epidemic and the threats it represents; their representation about the vaccine (and its harmlessness); their beliefs and representations about vaccination; the influence of the health professionals' opinion; the discussions between the patient and his acquaintances; and how the patient seeks for information.
CONCLUSION
These elements can be considered as criteria influencing the decision about any vaccination. They reflect the patient's subjectivity, the patient's perception of vaccination. Investigating these dimensions in the patient's mind can help the practitioner to positively influence the reluctant patients. Identifying threats and received ideas should allow the doctor to correct them and accept vaccination.
DOI: 10.1016/j.lpm.2012.04.031
PubMed: 23122940
Links to Exploration step
pubmed:23122940Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Criteria of the patient's decision concerning vaccination against influenza AH1N1, in Belgium and France].</title><author><name sortKey="Ketterer, Frederic" sort="Ketterer, Frederic" uniqKey="Ketterer F" first="Frédéric" last="Ketterer">Frédéric Ketterer</name><affiliation><nlm:affiliation>Université de Liège, département universitaire de médecine générale, 4000 Liège, Belgique. f.ketterer@ulg.ac.be</nlm:affiliation></affiliation></author><author><name sortKey="Goffin, Yves" sort="Goffin, Yves" uniqKey="Goffin Y" first="Yves" last="Goffin">Yves Goffin</name></author><author><name sortKey="Boyer, Pierre" sort="Boyer, Pierre" uniqKey="Boyer P" first="Pierre" last="Boyer">Pierre Boyer</name></author><author><name sortKey="Freyens, Anne" sort="Freyens, Anne" uniqKey="Freyens A" first="Anne" last="Freyens">Anne Freyens</name></author><author><name sortKey="Sourbes, Adeline" sort="Sourbes, Adeline" uniqKey="Sourbes A" first="Adeline" last="Sourbes">Adeline Sourbes</name></author><author><name sortKey="Belche, Jean Luc" sort="Belche, Jean Luc" uniqKey="Belche J" first="Jean-Luc" last="Belche">Jean-Luc Belche</name></author><author><name sortKey="Giet, Didier" sort="Giet, Didier" uniqKey="Giet D" first="Didier" last="Giet">Didier Giet</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23122940</idno><idno type="pmid">23122940</idno><idno type="doi">10.1016/j.lpm.2012.04.031</idno><idno type="wicri:Area/Main/Corpus">000050</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000050</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Criteria of the patient's decision concerning vaccination against influenza AH1N1, in Belgium and France].</title><author><name sortKey="Ketterer, Frederic" sort="Ketterer, Frederic" uniqKey="Ketterer F" first="Frédéric" last="Ketterer">Frédéric Ketterer</name><affiliation><nlm:affiliation>Université de Liège, département universitaire de médecine générale, 4000 Liège, Belgique. f.ketterer@ulg.ac.be</nlm:affiliation></affiliation></author><author><name sortKey="Goffin, Yves" sort="Goffin, Yves" uniqKey="Goffin Y" first="Yves" last="Goffin">Yves Goffin</name></author><author><name sortKey="Boyer, Pierre" sort="Boyer, Pierre" uniqKey="Boyer P" first="Pierre" last="Boyer">Pierre Boyer</name></author><author><name sortKey="Freyens, Anne" sort="Freyens, Anne" uniqKey="Freyens A" first="Anne" last="Freyens">Anne Freyens</name></author><author><name sortKey="Sourbes, Adeline" sort="Sourbes, Adeline" uniqKey="Sourbes A" first="Adeline" last="Sourbes">Adeline Sourbes</name></author><author><name sortKey="Belche, Jean Luc" sort="Belche, Jean Luc" uniqKey="Belche J" first="Jean-Luc" last="Belche">Jean-Luc Belche</name></author><author><name sortKey="Giet, Didier" sort="Giet, Didier" uniqKey="Giet D" first="Didier" last="Giet">Didier Giet</name></author></analytic><series><title level="j">Presse medicale (Paris, France : 1983)</title><idno type="eISSN">2213-0276</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Belgium</term><term>Decision Making</term><term>Female</term><term>France</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines</term><term>Influenza, Human (prevention & control)</term><term>Male</term><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Belgium</term><term>France</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Decision Making</term><term>Female</term><term>Humans</term><term>Male</term><term>Patient Acceptance of Health Care</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>We have analyzed the reasons evoked by the patients to decide or not to be vaccinated against AH1N1 influenza, in France and Belgium.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Semi-structured interviews were performed, recorded and transcribed for analysis. Fifty-eight interviews were performed with patient living in the region of Midi-Pyrénées, France (21 interviews) and in the province of Liège, Belgium (37 interviews). The patients were recruited by general practitioners. Within the sample, some patients were vaccinated against AH1N1 influenza and others were not.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Five criteria influenced the decision to be vaccinated or not: how people understand the epidemic and the threats it represents; their representation about the vaccine (and its harmlessness); their beliefs and representations about vaccination; the influence of the health professionals' opinion; the discussions between the patient and his acquaintances; and how the patient seeks for information.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>These elements can be considered as criteria influencing the decision about any vaccination. They reflect the patient's subjectivity, the patient's perception of vaccination. Investigating these dimensions in the patient's mind can help the practitioner to positively influence the reluctant patients. Identifying threats and received ideas should allow the doctor to correct them and accept vaccination.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23122940</PMID><DateCompleted><Year>2013</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-0276</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2013</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Presse medicale (Paris, France : 1983)</Title><ISOAbbreviation>Presse Med</ISOAbbreviation></Journal><ArticleTitle>[Criteria of the patient's decision concerning vaccination against influenza AH1N1, in Belgium and France].</ArticleTitle><Pagination><MedlinePgn>e63-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lpm.2012.04.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0755-4982(12)00525-8</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">We have analyzed the reasons evoked by the patients to decide or not to be vaccinated against AH1N1 influenza, in France and Belgium.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Semi-structured interviews were performed, recorded and transcribed for analysis. Fifty-eight interviews were performed with patient living in the region of Midi-Pyrénées, France (21 interviews) and in the province of Liège, Belgium (37 interviews). The patients were recruited by general practitioners. Within the sample, some patients were vaccinated against AH1N1 influenza and others were not.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five criteria influenced the decision to be vaccinated or not: how people understand the epidemic and the threats it represents; their representation about the vaccine (and its harmlessness); their beliefs and representations about vaccination; the influence of the health professionals' opinion; the discussions between the patient and his acquaintances; and how the patient seeks for information.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These elements can be considered as criteria influencing the decision about any vaccination. They reflect the patient's subjectivity, the patient's perception of vaccination. Investigating these dimensions in the patient's mind can help the practitioner to positively influence the reluctant patients. Identifying threats and received ideas should allow the doctor to correct them and accept vaccination.</AbstractText><CopyrightInformation>Copyright © 2012 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ketterer</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Université de Liège, département universitaire de médecine générale, 4000 Liège, Belgique. f.ketterer@ulg.ac.be</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goffin</LastName><ForeName>Yves</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Boyer</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Freyens</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sourbes</LastName><ForeName>Adeline</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Belche</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Giet</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Critères de décision du patient concernant la vaccination contre la grippe AH1N1, en Belgique et en France.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2012</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Presse Med</MedlineTA><NlmUniqueID>8302490</NlmUniqueID><ISSNLinking>0755-4982</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="Y">Patient Acceptance of Health Care</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>04</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23122940</ArticleId><ArticleId IdType="pii">S0755-4982(12)00525-8</ArticleId><ArticleId IdType="doi">10.1016/j.lpm.2012.04.031</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeBelgiqueV4/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000050 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000050 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeBelgiqueV4
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:23122940
|texte= [Criteria of the patient's decision concerning vaccination against influenza AH1N1, in Belgium and France].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:23122940" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a GrippeBelgiqueV4
| This area was generated with Dilib version V0.6.35. |  |